tiprankstipranks
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI

Brainstorm Cell Therapeutics (BCLI) Technical Analysis

490 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
0Neutral
9Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 0.57, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.541, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 0.49, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.541, making it a Buy.

Brainstorm Cell Therapeutics (BCLI) Pivot Points

Apr 18, 2024, 11:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
Fibonacci
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Brainstorm Cell Therapeutics (BCLI) Moving Averages

Apr 18, 2024, 11:45 AM
Period
Simple
Exponential
MA5
0.56Sell
0.56Sell
MA10
0.60Sell
0.58Sell
MA20
0.61Sell
0.57Sell
MA50
0.45Buy
0.49Buy
MA100
0.37Buy
0.51Buy
MA200
0.70Sell
0.96Sell
Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 0.58, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.541, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 0.51, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.541, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.541 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 0.45, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.541 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 0.37, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.541 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 0.70, creating a Sell signal.

Brainstorm Cell Therapeutics (BCLI) Technical Indicators

Apr 18, 2024, 11:45 AM
Name
Value
Implied Action
ROC
-10.00
Sell
Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is -10.00, creating a Sell signal.

FAQ

Is BCLI a Buy, Hold, or Sell?
Based on BCLI’s technical indicators, BCLI is a Sell.
    What is BCLI’s RSI (14)?
    Currently, no data Available
    What is BCLI’s MACD?
    Currently, no data Available
    What is BCLI’s 5-day moving average?
    BCLI’s 5-day moving average is 0.56, which suggests BCLI is a Sell.
      What is BCLI’s 20-day moving average?
      BCLI 20-day moving average is 0.61, which suggests BCLI is a Sell.
        What is BCLI’s 50-day moving average?
        BCLI’s 50-day moving average is 0.45, which suggests BCLI is a Buy.
          What is BCLI’s 200-day moving average?
          BCLI’s 200-day moving average is 0.70, which suggests BCLI is a Sell.
            What is BCLI’s Williams % R (14)?
            Currently, no data Available
            What is BCLI’s CCI (14)?
            Currently, no data Available
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis